OXFORD BIOMEDICA PLC (OXB) — research page

UK · uk-cm-kg/LSE/OXB · as of 2026-11-06

Identity and listing

The issuer is OXFORD BIOMEDICA PLC, listed on the LSE Main Market under ticker OXB, with ISIN GB00BDFBVT43 and LEI 213800S1GVQNXQ15K851. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

The disclosure read

The record holds 282 filings on 104 filing days in the twelve months to 2026-11-06. The median gap between filing days is 2 days. The latest filing is dated 2026-11-06, 0 days before the record date, and is of type ch_capital. The LSE Main Market median is 29.0 filings, a median cadence gap of 4 days and a median latency of 3 days across 892 issuers. The Pharmaceuticals and Biotechnology [201030] sector median is 42 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 51 issuers. The filings by type are: regulatory_announcement 102, early_warning 76, ch_capital 69, corporate_action 23, director_dealing 5, agm_record_date 2, financial_statement 3, ch_accounts_filed 1 and ch_resolution 1.

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.

Orderability

For the elective professional client category, the outcome is signal ACM-200 and is determinable. For the eligible counterparty category, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 8 research houses: Deutsche Numis, Investec, Jefferies, JP Morgan, Panmure Liberum, Peel Hunt, RBC and Stifel.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-11. Years 2021 through 2026 are held in the store but not served as of a date; the as-of door answers not_sealed.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)

10.2

https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OXB (identity.isin)

10.3

https://find-and-update.company-information.service.gov.uk/company/03252665 (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://www.londonstockexchange.com/stock/OXB/oxford-biomedica-plc/company-page (identity.sector)

10.6

https://mcp.uk-cm-kg.ai/events/LSE/OXB (the disclosure lines)

10.7

https://marketsecurities.fca.org.uk/officiallist (the halt flag)

10.8

https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)

10.9

https://oxb.com/investors/analyst-coverage/ (coverage)

10.10

https://mcp.uk-cm-kg.ai/record/LSE/OXB (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BDFBVT43"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:98880e19f431e530.